• Latest Posts

C2i Genomics extends AstraZeneca cancer deal

New targeted drug shows benefit against breast cancer in first phase III trial

Beyond Biotech podcast 25: Center for Global Development, Humacyte, Transgene

More News! 8 Dec 2022

Enhertu’s positive results demonstrate improvement in overall survival

AstraZeneca splashes out up to $320M on T-cell receptor therapy company

Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca

ADVERTISEMENT

AstraZeneca and Daiichi Sankyo’s Enhertu recommended for approval

Interview 14 Nov 2022

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

More News! 4 Nov 2022

Sanofi and AstraZeneca drug, Beyfortus, for RSV in babies and children approved

Illumina and AstraZeneca look to drug target discovery with ‘pivotal research collaboration’

ASPIRE set up to collaborate on amyloidosis

Alexion, AstraZeneca Rare Disease to acquire genomic medicine company LogicBio Therapeutics 

ADVERTISEMENT